These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26111072)

  • 1. MELD-Na as a prognostic indicator of 30- and 90-day mortality in patients with end-stage liver disease after creation of transjugular intrahepatic portosystemic shunt.
    Ahmed R; Santhanam P; Rayyan Y
    Eur J Gastroenterol Hepatol; 2015 Oct; 27(10):1226-7. PubMed ID: 26111072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation.
    Gaba RC; Couture PM; Bui JT; Knuttinen MG; Walzer NM; Kallwitz ER; Berkes JL; Cotler SJ
    J Vasc Interv Radiol; 2013 Mar; 24(3):411-20, 420.e1-4; quiz 421. PubMed ID: 23312989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.
    Ferral H; Gamboa P; Postoak DW; Albernaz VS; Young CR; Speeg KV; McMahan CA
    Radiology; 2004 Apr; 231(1):231-6. PubMed ID: 14990811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
    Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
    Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
    Young S; Rostambeigi N; Golzarian J; Lim N
    AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of transjugular intrahepatic portosystemic shunt creation on intermediate-term model for end-stage liver disease score progression.
    Casadaban LC; Gabra MG; Parvinian A; Minocha J; Knuttinen MG; Bui JT; Gaba RC
    Transplant Proc; 2014 Jun; 46(5):1384-8. PubMed ID: 24935301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.
    King A; Masterton G; Gunson B; Olliff S; Redhead D; Mangat K; Oniscu G; Hayes P; Tripathi D
    Liver Transpl; 2011 Jul; 17(7):771-8. PubMed ID: 21714062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin-bilirubin grade versus MELD score for predicting survival after transjugular intrahepatic portosystemic shunt (TIPS) creation.
    Ronald J; Wang Q; Choi SS; Suhocki PV; Hall MD; Smith TP; Kim CY
    Diagn Interv Imaging; 2018 Mar; 99(3):163-168. PubMed ID: 29154015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunt placement for refractory ascites: a single-centre experience.
    Lodato F; Berzigotti A; Lisotti A; Azzaroli F; Mosconi C; Giampalma E; Renzulli M; Cappelli A; Buonfiglioli F; Calvanese C; Zoli M; Golfieri R; Mazzella G
    Scand J Gastroenterol; 2012 Dec; 47(12):1494-500. PubMed ID: 22958120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
    Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
    Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older patient age may predict early mortality after transjugular intrahepatic portosystemic shunt creation in individuals at intermediate risk.
    Parvinian A; Shah KD; Couture PM; Minocha J; Knuttinen MG; Bui JT; Gaba RC
    J Vasc Interv Radiol; 2013 Jul; 24(7):941-6. PubMed ID: 23707226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of early mortality after transjugular intrahepatic portosystemic shunt creation for the treatment of refractory ascites.
    Harrod-Kim P; Saad WE; Waldman D
    J Vasc Interv Radiol; 2006 Oct; 17(10):1605-10. PubMed ID: 17057001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MELD score as a predictor of early death in patients undergoing elective transjugular intrahepatic portosystemic shunt (TIPS) procedures.
    Montgomery A; Ferral H; Vasan R; Postoak DW
    Cardiovasc Intervent Radiol; 2005; 28(3):307-12. PubMed ID: 15886944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Liver Failure after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis with Model for End-Stage Liver Disease Score of 12 or Less: Incidence, Outcome, and Prognostic Factors.
    Luca A; Miraglia R; Maruzzelli L; D'Amico M; Tuzzolino F
    Radiology; 2016 Aug; 280(2):622-9. PubMed ID: 26982564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).
    Delgado MG; Mertineit N; Bosch J; Baumgartner I; Berzigotti A
    Dig Liver Dis; 2024 Sep; 56(9):1544-1550. PubMed ID: 38555198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No Increased Mortality After TIPS Compared with Serial Large Volume Paracenteses in Patients with Higher Model for End-Stage Liver Disease Score and Refractory Ascites.
    Ronald J; Rao R; Choi SS; Kappus M; Martin JG; Sag AA; Pabon-Ramos WM; Suhocki PV; Smith TP; Kim CY
    Cardiovasc Intervent Radiol; 2019 May; 42(5):720-728. PubMed ID: 30603968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different scoring systems in predicting survival in Chinese patients with liver cirrhosis undergoing transjugular intrahepatic portosystemic shunt.
    Zhang F; Zhuge Y; Zou X; Zhang M; Peng C; Li Z; Wang T
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):853-60. PubMed ID: 24915489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison study of five scoring systems for evaluating prognosis of patients undergoing transjugular intrahepatic portosystemic shunt procedures].
    Wen L; He S; Zhang H; Luo X
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jul; 22(7):514-8. PubMed ID: 25203803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transjugular intrahepatic portosystemic shunts in liver transplant recipients: technical analysis and clinical outcome.
    Saad WE; Darwish WM; Davies MG; Kumer S; Anderson C; Waldman DL; Schmitt T; Matsumoto AH; Angle JF
    AJR Am J Roentgenol; 2013 Jan; 200(1):210-8. PubMed ID: 23255764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.